Table 5 Comparison of baseline and post-treatment SUV in PD, SD, and PR groups
From: Role of PET/CT in post-therapeutic assessment of bronchogenic carcinoma
Progressive disease (N = 3) | Stable disease (N = 9) | Partial response (N = 7) | |||||||
|---|---|---|---|---|---|---|---|---|---|
Pre-treatment | Post-treatment | P-value | Pre-treatment | Post-treatment | P-value | Pre-treatment | Post-treatment | P-value | |
SUV | |||||||||
Mean | 5.97 | 12.37 | 0.14 | 17.23 | 13.41 | 0.09 | 14.04 | 5.3 | 0.0006 |
SD | 3.85 | 8.54 | 11.25 | 8.82 | 3.15 | 2.17 | |||